School of Pharmaceutical Science, Shandong University, 44 West Wenhua Road, Jinan, Shandong Province, 250012, PR China.
Int J Pharm. 2013 Aug 16;452(1-2):108-15. doi: 10.1016/j.ijpharm.2013.04.072. Epub 2013 May 3.
In the present study, the self-assembly properties, aggregation behavior and potential application of mixed samples formed by an active drug (diclofenac sodium, DS) and conventional surfactant (didodecyldimethyl ammonium bromide, DDAB) are investigated with surface tension, transmission electron microscope (TEM), dynamic light scattering (DLS), zeta potential, conductivity, in vitro drug release and hemolytic toxicity measurements. The physicochemical parameters such as critical micelle concentration (CMC), the surface tension at CMC (γCMC), the maximum surface excess concentration (Γ max) and the minimum area per molecule headgroup at the air/water interface (A min) and degree of counterion binding (β) are obtained from the surface tension and electrical conductivity measurements. The results show that diclofenac sodium can decrease the surface tension of water and aggregate in the aqueous solution when its concentration is large enough. The CMC and γCMC of the DS/DDAB mixed systems are found to have values between that of individual DS and DDAB solutions. TEM and DLS results demonstrate the formation of spherical vesicles in a wide range of the molar ratio of the two components. The amount of charge on the vesicles and their stability can be tuned by controlling the amount of drug and surfactant. To evaluate the potential use of the as-prepared DS/DDAB catanionic vesicles in drug delivery systems, the in vitro drug release and hemolytic toxicity are carried out. The results indicate that both the drug release behavior and the hemolytic toxicity are dependent on the composition of the samples, X1 (X1=nDS/n(DS+DDAB), decreasing with the decrease of X1. The results of this work suggested that the drug-participating catanionic vesicles can be used as a safe and an efficient vehicle for sustained drug release.
在本研究中,通过表面张力、透射电子显微镜(TEM)、动态光散射(DLS)、动电电位、电导率、体外药物释放和溶血毒性测量,研究了活性药物(双氯芬酸钠,DS)和常规表面活性剂(双十二烷基二甲基溴化铵,DDAB)混合样品的自组装特性、聚集行为和潜在应用。从表面张力和电导率测量中获得了临界胶束浓度(CMC)、CMC 时的表面张力(γCMC)、最大表面过剩浓度(Γmax)和空气/水界面最小分子头基面积(Amin)以及抗衡离子结合度(β)等物理化学参数。结果表明,当双氯芬酸钠的浓度足够大时,它可以降低水的表面张力并在水溶液中聚集。DS/DDAB 混合体系的 CMC 和γCMC 值介于单个 DS 和 DDAB 溶液之间。TEM 和 DLS 结果表明,在两个组分的摩尔比很宽的范围内形成了球形囊泡。通过控制药物和表面活性剂的用量,可以调节囊泡上的电荷量及其稳定性。为了评估所制备的 DS/DDAB 双阳离子囊泡在药物传递系统中的潜在应用,进行了体外药物释放和溶血毒性实验。结果表明,药物释放行为和溶血毒性都依赖于样品的组成,X1(X1=nDS/n(DS+DDAB)随着 X1 的减小而降低。本工作的结果表明,参与药物的双阳离子囊泡可用作安全有效的持续药物释放载体。